--- title: "Stroke FASTEST | Sutter Health" description: "Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered At Earliest Time (FASTEST) Trial" url: "https://www.sutterhealth.org/research/clinical-trials/stroke-fastest-1049141798" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Clinical trials](https://www.sutterhealth.org/research/clinical-trials) / 4. Stroke FASTEST # Stroke FASTEST **Status:** Open to Enrollment [Email us to enroll](https://www.sutterhealth.org/research/clinical-trials/stroke-fastest-1049141798#enroll) #### Study details View study details on [clinicaltrials.gov](https://clinicaltrials.gov/ct2/show/NCT03496883). #### Locations - Burlingame #### Clinical trial FAQs Information for patients and study volunteers, including [frequently asked questions](https://www.sutterhealth.org/research/faqs). Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial Please contact: [fastest@sutterhealth.org](mailto:fastest@sutterhealth.org) about study FASTEST More information about the study can be found here: [https://www.nihstrokenet.org/fastest/home](https://www.nihstrokenet.org/fastest/home) ****This research study may affect you or someone you know. Before the research study starts, we will consult with the community. We welcome your feedback and questions. Please click on the survey link below to let us know your thoughts. Thank you!**** [https://redcap.research.cchmc.org/surveys/?s=YALHC7W838](https://redcap.research.cchmc.org/surveys/?s=YALHC7W838) ![Ilana Spokoyny, M.D.](https://dyn.mktgcdn.com/p/aTEvqdezOIrn1AaNQZgKnkolM1634Rgk08Ga3QurGQU/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100) Ilana Spokoyny, M.D. Principal investigator [View profile](https://www.sutterhealth.org/research/investigators/ilana-spokoyny-md-1049680993) ## Sub-Investigator [Nobl Barazangi, M.D., Ph.D.](https://www.sutterhealth.org/research/investigators/nobl-barazangi-md-phd-1049681166) ## Email us to enroll - [Email Burlingame](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Stroke%20FASTEST%20in%20Burlingame&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) ## Related clinical trials [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) - Clinical trial ### [Acute Ischemic Stroke PICASSO](https://www.sutterhealth.org/research/clinical-trials/acute-ischemic-stroke-picasso-1094825919) Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial **Status:** Open to Enrollment - Clinical trial ### [ALS Healey Platform Trial Master Protocol](https://www.sutterhealth.org/research/clinical-trials/als-healey-platform-trial-master-protocol-2057369170) HEALEY ALS Platform Trial **Status:** Closed to Enrollment - Clinical trial ### [ALS SPG302 Expanded Access Protocol](https://www.sutterhealth.org/research/clinical-trials/als-spg302-expanded-access-protocol-2036968358) Intermediate-size Patient Population Expanded Access Protocol for SPG302 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS) **Status:** Open to Enrollment - Clinical trial ### [Amyotrophic Lateral Sclerosis (ALS) C302-CLN-2301](https://www.sutterhealth.org/research/clinical-trials/amyotrophic-lateral-sclerosis-als-c302-cln-2301-2044044761) Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, 24-Week Study With Additional 24-Week Blinded Active Extension to Evaluate the Safety and Efficacy of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) **Status:** Open to Enrollment - Clinical trial ### [Amyotrophic Lateral Sclerosis (ALS) PL101-ALS301 PREVAILS](https://www.sutterhealth.org/research/clinical-trials/amyotrophic-lateral-sclerosis-als-pl101-als301-prevails-2064309735) A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pridopidine in Participants With Amyotrophic Lateral Sclerosis **Status:** Open to Enrollment [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/clinical-trials/stroke-fastest-1049141798#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Clinical trials","item":"https://www.sutterhealth.org/research/clinical-trials"},{"@type":"ListItem","position":4,"name":"Stroke FASTEST"}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/clinical-trials/stroke-fastest-1049141798#medicalwebpage","name":"Stroke FASTEST","description":"Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered At Earliest Time (FASTEST) Trial","url":"https://www.sutterhealth.org/research/clinical-trials/stroke-fastest-1049141798","inLanguage":"en-US","dateModified":"2026-05-19","publisher":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"},"medicalAudience":{"@type":"MedicalAudience","audienceType":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/clinical-trials/stroke-fastest-1049141798#medicaltrial"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/clinical-trials/stroke-fastest-1049141798#breadcrumblist"},"mentions":[{"@type":"Person","name":"Ilana Spokoyny, M.D.","url":"https://www.sutterhealth.org/research/investigators/ilana-spokoyny-md-1049680993","jobTitle":"Principal Investigator","affiliation":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"}}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalTrial","@id":"https://www.sutterhealth.org/research/clinical-trials/stroke-fastest-1049141798#medicaltrial","name":"Stroke FASTEST","alternateName":"Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered At Earliest Time (FASTEST) Trial","url":"https://www.sutterhealth.org/research/clinical-trials/stroke-fastest-1049141798","description":"Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial Please contact: fastest@sutterhealth.org about study FASTEST More information about the study can be found here: https://www.nihstrokenet.org/fastest/home This research study may affect you or someone you know. Before the research study starts, we will consult with the community. We welcome your feedback and questions. Please click on the survey link below to let us know your thoughts. Thank you! https://redcap.research.cchmc.org/surveys/?s=YALHC7W838","identifier":"NCT03496883","code":{"@type":"MedicalCode","codeValue":"NCT03496883","codingSystem":"ClinicalTrials.gov"},"sameAs":"https://clinicaltrials.gov/ct2/show/NCT03496883","status":"https://schema.org/Recruiting","healthCondition":[{"@type":"MedicalCondition","name":"Stroke"}],"studyLocation":[{"@type":"AdministrativeArea","name":"Burlingame"}]} ```